Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.

Hypertension research : official journal of the Japanese Society of Hypertension - 1 Dec 2006

Kawaguchi Hideki, Masuo Kazuko, Katsuya Tomohiro, Sugimoto Ken, Rakugi Hiromi, Ogihara Toshio, Tuck Michael L

Abstract excerpt

High blood pressure (BP) is a major determinant of cardiovascular events in obesity. The beta2- and beta3-adrenoceptor polymorphisms are associated with obesity and hypertension. In the present study, we examine the relationships of beta2- and beta3-adrenoceptor polymorphisms with further weight...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Pressure
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension

Share to Leptin

Share to Norepinephrine

Share to Receptors, Adrenergic, beta-2

Share to Receptors, Adrenergic, beta-3

Share to Weight Gain

Source

Identifiers

PMID: 17378367
DOI: 10.1291/hypres.29.951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17378367-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.PMID 17378367Read ↗

Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.Semantic proximity Read ↗

Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.Semantic proximity Read ↗

beta(3) Adrenergic receptor polymorphism and obesity-related phenotypes in hypertensive patients.Semantic proximity Read ↗

Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population.Semantic proximity Read ↗

The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with weight changes in obese Japanese men: a 4-year follow-up study.Semantic proximity Read ↗

High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.Semantic proximity Read ↗

The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins.Semantic proximity Read ↗

Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population.Semantic proximity Read ↗

Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels.Semantic proximity Read ↗

Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is associated with increased plasma leptin levels in obese Chinese women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.